- Home
- OS vs CORT Comparison
OS vs CORT Comparison
Compare OS & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OS
- CORT
- Stock Information
- Founded
- OS 2012
- CORT 1998
- Country
- OS United States
- CORT United States
- Employees
- OS N/A
- CORT N/A
- Industry
- OS
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- OS
- CORT Health Care
- Exchange
- OS NYSE
- CORT Nasdaq
- Market Cap
- OS 6.7B
- CORT 7.1B
- IPO Year
- OS 2024
- CORT N/A
- Fundamental
- Price
- OS $19.66
- CORT $62.24
- Analyst Decision
- OS Strong Buy
- CORT Strong Buy
- Analyst Count
- OS 20
- CORT 4
- Target Price
- OS $33.32
- CORT $143.25
- AVG Volume (30 Days)
- OS 1.1M
- CORT 2.5M
- Earning Date
- OS 05-08-2025
- CORT 04-30-2025
- Dividend Yield
- OS N/A
- CORT N/A
- EPS Growth
- OS N/A
- CORT 30.85
- EPS
- OS N/A
- CORT 1.23
- Revenue
- OS $489,407,000.00
- CORT $675,040,000.00
- Revenue This Year
- OS $23.03
- CORT $36.81
- Revenue Next Year
- OS $20.65
- CORT $32.00
- P/E Ratio
- OS N/A
- CORT $50.60
- Revenue Growth
- OS 30.54
- CORT 39.94
- 52 Week Low
- OS $16.69
- CORT $20.84
- 52 Week High
- OS $35.39
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- OS N/A
- CORT 45.43
- Support Level
- OS N/A
- CORT $65.07
- Resistance Level
- OS N/A
- CORT $71.15
- Average True Range (ATR)
- OS 0.00
- CORT 8.92
- MACD
- OS 0.00
- CORT -1.67
- Stochastic Oscillator
- OS 0.00
- CORT 0.54
About OS ONESTREAM INC
OneStream Inc is an AI-enabled and extensible software platform that unifies core financial functions and broader operational data and processes within a single platform. The Digital Finance Cloud of the company provides a comprehensive, dynamic, and predictive view of the entire enterprise, providing corporate leaders the control, visibility, and agility required to proactively adjust business and day-to-day execution.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.